Grifols, S.A. (ADR)

General ticker "GRFS" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $6.1B (TTM average)

Grifols, S.A. (ADR) does not follow the US Stock Market performance with the rate: -3.5%.

Estimated limits based on current volatility of 1.4%: low 7.58$, high 7.79$

Factors to consider:

  • Company pays dividends (semi-annually): last record date 2025-08-12, amount 0.18$ (Y4.82%)
  • Total employees count: 157 as of 2010
  • Current price 11.7% below estimated low
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [8.46$, 13.25$]
  • 2026-12-31 to 2027-12-31 estimated range: [10.23$, 15.51$]

Financial Metrics affecting the GRFS estimates:

  • Positive: with PPE of 11.4 at the end of fiscal year the price was low
  • Positive: Operating cash flow per share per price, % of 19.12 > 12.90
  • Positive: 7.54 < Operating profit margin, % of 16.43
  • Positive: Industry earnings per price (median), % of 5.49 > 4.45
  • Positive: Industry inventory ratio change (median), % of 0.28 <= 0.28
  • Negative: Interest expense per share per price, % of 11.41 > 3.31
  • Negative: Investing cash flow per share per price, % of -10.57 <= -4.41
  • Negative: Industry operating cash flow per share per price (median), % of 5.61 <= 10.39
  • Negative: Return on assets ratio (scaled to [-100,100]) of 2.37 <= 6.06

Similar symbols

Short-term GRFS quotes

Long-term GRFS plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue €7,212.38MM €7,227.05MM
Operating Expenses €6,020.37MM €6,039.83MM
Operating Income €1,192.02MM €1,187.22MM
Non-Operating Income €-748.02MM €-596.49MM
Interest Expense €773.15MM €600.33MM
R&D Expense €384.04MM €358.28MM
Income(Loss) €444.00MM €590.73MM
Taxes €231.19MM €110.46MM
Net Income(Loss)* €156.92MM €386.13MM
Stockholders Equity €5,883.73MM €5,268.76MM
Inventory €3,560.10MM €3,294.60MM
Assets €21,405.24MM €19,749.59MM
Operating Cash Flow €902.17MM €1,005.68MM
Capital expenditure €371.37MM €254.54MM
Investing Cash Flow €886.67MM €-556.15MM
Financing Cash Flow €-1,358.71MM €-508.12MM
Earnings Per Share** €0.23 €0.57
Ordinary share to ADR 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.